side effect of semaglutide The FDA sent a warning letter to the maker Ozempic and Wegovy over unreported potential GLP-1 effects. Here's what to know Weighing up the Risks: GI

*We never came back to this

The IDF further estimates that by 2050, 1 in 8 adults, roughly 853 million, will have diabetes, marking a 46% increase

This special will bring together medical experts, leaders in the space and people in the day-to-day struggle to talk about health equity and obesity with the intention to ultimately release the shame, judgment and stigma surrounding weight. GLP-1 receptor agonists, a class of drugs initially developed to treat type 2 diabetes, have been found to have significant effects on weight loss

The Cleveland Clinic draws an important line: theres a difference between microdosing compounded versions of GLP-1s and working with your doctor to adjust the dose of an FDA-approved medication